Oxaliplatin and 5-fluorouracil (FOLFOX) in advanced well-differentiated digestive neuroendocrine tumors: a multicenter national retrospective study from the French Group of Endocrine Tumors (GTE)

Paul GIROT  ¹     E. Baudin  ²     Hélène Senellart  ³     Nadia Bouarioua  ⁴     Olivia Hentic-Dhomé  ⁵     R. Guimbaud  ⁶     Thomas Walter  ⁷     Aurélie Ferru     Guillaume Roquin     Guillaume Cadiot     Marc Pracht     Jean-Baptiste Girot     David Malka     Michel Ducreux     Julien Hadoux     Tamara Matysiak Budnik     Yann Touchefeu    
¹ CHD Vendée La Roche Sur Yon,La Roche Sur Yon,France
² Institut Gustave Roussy,Villejuif,France
³ Institut de Cancérologie de L'Ouest,Saint Herblain,France
⁴ University Hospital of Saint-Etienne,Saint Priest en Jarez,France
⁵ Hopital Beaujon, APHP, Université Denis Diderot,Beaujon,France
⁶ CHU Rangueil,Toulouse,France
⁷ Hospices

Session
New frontiers in pancreatic neoplasias

Conference
UEG Week 2019

Citation
United European Gastroenterology Journal Volume 7 Issue 8 (Supplement), October 2019